A detailed history of Principal Securities, Inc. transactions in Humacyte, Inc. stock. As of the latest transaction made, Principal Securities, Inc. holds 500 shares of HUMA stock, worth $2,715. This represents 0.0% of its overall portfolio holdings.

Number of Shares
500
Previous 1,000 50.0%
Holding current value
$2,715
Previous $4.8 Million 43.33%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

SELL
$5.11 - $9.46 $2,555 - $4,730
-500 Reduced 50.0%
500 $2.72 Million
Q2 2024

Jul 31, 2024

BUY
$2.87 - $9.1 $2,870 - $9,100
1,000 New
1,000 $4.8 Million

Others Institutions Holding HUMA

About Humacyte, Inc.


  • Ticker HUMA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 103,007,000
  • Market Cap $559M
  • Description
  • Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular ...
More about HUMA
Track This Portfolio

Track Principal Securities, Inc. Portfolio

Follow Principal Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Principal Securities, Inc. with notifications on news.